secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0000950142-21-002677
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals CFO William Fricker to leave Aug 30; James Brandon named Acting CFO
--------------------------------------------------------------------------------

- William Fricker to depart as CFO and Treasurer effective August 30, 2021; no disagreements cited.
- James Brandon to serve as Comptroller and Acting CFO; Alessandra Daigneault as Acting Treasurer.
- Ira Strassberg hired as financial consultant to lead CFO recruitment; previously Deputy CFO of Cantor Fitzgerald.
- Fricker will receive a $100,000 annual bonus for completing his employment contract.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/0000950142-21-002677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/eh210178862_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-21-002677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer